Kevin Katz, MD

Head, Microbiology
North York General Hospital, Canada

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-40) Impact of case and control selection on influenza vaccine effectiveness (VE) among adults aged 40 years and older hospitalized with acute respiratory illness (ARI) during 2022-2023 using a test negative design (TND): secondary analysis of the North America multi-specimen study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-225) Effect of isolating Clostridioides difficile asymptomatic carriers on the incidence of healthcare-associated C. difficile infections: a systematic review and meta-analysis
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT